|
Volumn 374, Issue 22, 2016, Pages 2188-
|
To the editor
|
Author keywords
[No Author keywords available]
|
Indexed keywords
HUMAN;
LETTER;
LUNG TUBERCULOSIS;
MORTALITY;
PRIORITY JOURNAL;
TREATMENT DURATION;
TUBERCULOUS MENINGITIS;
AIDS-RELATED OPPORTUNISTIC INFECTIONS;
FEMALE;
MALE;
TUBERCULOSIS, MENINGEAL;
LEVOFLOXACIN;
RIFAMPICIN;
TUBERCULOSTATIC AGENT;
AIDS-RELATED OPPORTUNISTIC INFECTIONS;
ANTITUBERCULAR AGENTS;
FEMALE;
HUMANS;
LEVOFLOXACIN;
MALE;
RIFAMPIN;
TUBERCULOSIS, MENINGEAL;
|
EID: 84973333024
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMc1602291 Document Type: Letter |
Times cited : (2)
|
References (3)
|